Immunology Basics

Immunology — Deep Dive

Part 1 of 4 — Innate Immunity: Barriers, Cells & Inflammation

The First Line: Barriers Before Cells

Before any immune cell acts, physical and chemical barriers exclude most pathogens:

• Skin: keratinized epithelium, dry and slightly acidic; sweat and sebum inhibit growth
• Mucus in respiratory and GI tracts traps microbes; the mucociliary escalator sweeps them out
• Lysozyme (tears, saliva, mucus) cleaves bacterial peptidoglycan cell walls
• Stomach acid (pH ~2) destroys most swallowed microbes
• Defensins: antimicrobial peptides secreted by epithelial cells that punch holes in microbial membranes

Innate vs. Adaptive — The Framing Table

The Innate Cell Cast

• Neutrophils: most abundant leukocyte; first responders that phagocytose and die at the site (pus)
• Macrophages: tissue-resident phagocytes (from monocytes); engulf pathogens, release cytokines, present antigen
• Dendritic cells: the innate→adaptive bridge — they sample antigen in tissue, migrate to lymph nodes, and present it to naive T cells (the premier antigen-presenting cell)
• NK cells: lymphocyte-lineage but innate; kill host cells that LACK MHC I ("missing self" — virus-infected and tumor cells often downregulate MHC I to hide from T cells, and NK cells exploit exactly that)
• Eosinophils (parasites, allergy), basophils and mast cells (histamine release, allergy and inflammation)

Pattern Recognition: PRRs and PAMPs

Innate receptors are pattern recognition receptors (PRRs) — e.g., Toll-like receptors (TLRs) — that bind pathogen-associated molecular patterns (PAMPs): conserved microbial signatures like LPS, flagellin, and double-stranded RNA. This is why innate immunity is "nonspecific" yet not random: it recognizes broad classes of invaders with fixed, germline-encoded receptors, no prior exposure needed.

Complement

A cascade of ~30 plasma proteins (made mainly by the liver) with three effector outcomes:

1. Opsonization — the fragment C3b coats microbes, flagging them for phagocytosis
2. Membrane attack complex (MAC) — terminal components form a lytic pore in the pathogen membrane
3. Anaphylatoxins — small complement fragments that amplify inflammation and recruit phagocytes

• Component names: C3a and C5a are the anaphylatoxins, and C5a is also a strong neutrophil chemoattractant.

Activation routes at concept level: the classical pathway is triggered by antibody bound to antigen (so it links to adaptive immunity), while the alternative pathway fires spontaneously on microbial surfaces with no antibody required — purely innate.

Inflammation, Fever & Interferons

The inflammation cascade: tissue damage → mast cells release histamine → vasodilation (redness, heat) and increased capillary permeability (swelling) → neutrophils adhere to endothelium and squeeze out via diapedesis → follow chemical gradients (chemotaxis, e.g., toward complement fragments and bacterial products) to the site.

Fever: pyrogens (e.g., IL-1) reset the hypothalamic set point; moderate fever inhibits some pathogens and speeds immune reactions. Interferons are cytokines released by virus-infected cells that warn NEIGHBORING cells to degrade RNA and dampen protein synthesis — an antiviral state that slows viral spread before adaptive immunity arrives.

Worked Example — A Splinter, Hour by Hour

Passage-style problem. A student gets a wooden splinter contaminated with soil bacteria in her finger. Within hours the site is red, warm, swollen, and tender. By day 2 a small amount of pus has formed. She has never encountered this bacterial strain before, yet the infection is cleared by day 4 without antibiotics.

Question 1 — Why redness, heat, and swelling within hours? Damaged tissue and resident mast cells release histamine. Local arterioles dilate (more warm blood → redness and heat) and capillaries become leaky (plasma leaks out → swelling). This is the stereotyped innate inflammatory response — no recognition of the specific strain is required.

Question 2 — How do neutrophils "know" where to go? Bacterial products and complement fragments form a chemical gradient. Circulating neutrophils tether to activated endothelium, exit the vessel by diapedesis, and crawl up the gradient by chemotaxis. The pus at day 2 is largely dead neutrophils and debris.

Question 3 — The strain is new to her immune system. How can it be cleared in 4 days when adaptive responses take a week or more? Innate recognition does not need prior exposure: TLRs on macrophages and neutrophils bind conserved PAMPs (e.g., LPS on Gram-negative walls), and the alternative complement pathway opsonizes the bacteria spontaneously. Phagocytosis of C3b-coated bacteria clears the small inoculum before an adaptive response is even necessary.

Question 4 — Meanwhile, what are dendritic cells doing? Sampling bacterial antigen at the wound, then migrating through lymphatics to the draining lymph node to present peptides to naive T cells. Even though innate immunity wins this round, the adaptive system is being briefed — that hand-off is the dendritic cell's defining job.

Innate Immunity & Inflammation 🎯

Key Takeaways — Part 1

• Barriers first: skin, mucus, lysozyme, stomach acid, defensins exclude most pathogens before any cell responds
• Innate = fast, pattern-based (PRRs like TLRs binding PAMPs), germline-encoded, no memory; adaptive = slow first time, epitope-specific, with memory
• Dendritic cells are the innate→adaptive bridge: capture antigen in tissue, present it to naive T cells in lymph nodes
• NK cells kill host cells LACKING MHC I ("missing self") — the counter to viral MHC downregulation
• Complement: opsonization (C3b), MAC lysis, anaphylatoxins; classical = antibody-triggered, alternative = spontaneous on microbial surfaces
• Inflammation sequence: histamine → vasodilation and permeability → adhesion → diapedesis → chemotaxis; fever and interferons buy time against pathogens system-wide

• Low-yield extras: C3a and C5a are the anaphylatoxins (C5a is also a neutrophil chemoattractant)

Immunology — Deep Dive

Part 2 of 4 — Adaptive Immunity: T Cells, B Cells & MHC

MHC I vs. MHC II — The Highest-Yield Pairing in Immunology

Memory hook: the products multiply to eight — MHC I $\times$ CD8, MHC II $\times$ CD4. A cell displaying viral peptide on MHC I is confessing to internal infection and invites CD8+ killing; an APC displaying bacterial peptide on MHC II is reporting extracellular danger and recruits CD4+ help.

T-Cell Development: Education in the Thymus

T-cell precursors leave the bone marrow and mature in the thymus, where two filters create central tolerance:

1. Positive selection: thymocytes whose receptors can bind self-MHC at all survive; useless receptors die by neglect. (Must be able to READ the MHC bookshelf.)
2. Negative selection: thymocytes that bind self-peptide/self-MHC TOO strongly are deleted. (Must not ATTACK the library's own books.)

The survivors are self-MHC-restricted but self-tolerant. Failure of negative selection is a root cause of autoimmunity (Part 4).

Helper T Cells: The Conductors

CD4+ helper T cells do not kill; they coordinate via cytokines:

• Th1 cells promote CELL-MEDIATED immunity — they activate macrophages and support cytotoxic T cells (intracellular pathogens)
• Th2 cells promote HUMORAL immunity — they help B cells produce antibody, and drive responses to parasites and allergy

Losing helper T cells (as in HIV) cripples BOTH arms — antibodies and killing — which is why CD4 count predicts immune collapse.

Cytotoxic T Cells: The Executioners

CD8+ T cells recognize antigen on MHC I and kill the presenting cell by:

• Perforin — pore-forming protein — plus granzymes, proteases that enter and trigger apoptosis
• Fas ligand engaging Fas on the target, again inducing apoptosis

Death is by tidy apoptosis, not lysis-and-spill: the infected cell dismantles itself without releasing virions freely.

B Cells and the Two Activation Routes

• T-dependent antigens (most proteins): the B cell binds antigen with its BCR, internalizes and presents it on MHC II; a matching helper T cell provides a contact (co-stimulatory) signal and cytokines. Full response: class switching, affinity maturation, memory.

• The contact signal is CD40 ligand (CD40L) on the helper T cell engaging CD40 on the B cell.

• T-independent antigens (highly repetitive structures like bacterial polysaccharides): massive BCR cross-linking activates the B cell alone — but mostly IgM, weak memory.

Clonal Selection & Receptor Diversity

Clonal selection: the repertoire of lymphocytes, each with ONE unique receptor specificity, exists BEFORE antigen arrives. Antigen merely selects the matching clones, which then undergo clonal expansion into effector cells and memory cells.

Why does the repertoire pre-exist? V(D)J recombination: during lymphocyte development, one Variable, one Diversity (present in antibody heavy chains and TCR beta and delta chains; light chains and TCR alpha have none), and one Joining gene segment are randomly cut-and-pasted together (somatic recombination), and imprecise joining adds or removes nucleotides at the junctions (junctional diversity). Combinatorial choice, junctional randomness, and heavy-light pairing generate billions of specificities from a modest genome — no instruction from the antigen needed.

Worked Example — Tracing One Virus Through the Adaptive System

Passage-style problem. A respiratory virus infects airway epithelial cells. A dendritic cell in the airway engulfs debris from a dying infected cell and also becomes directly infected itself. It migrates to a draining lymph node.

Question 1 — Which MHC molecules on the dendritic cell display viral peptide, and to which T cells? Both. Peptides from ENGULFED debris are exogenous → processed into the MHC II pathway → presented to CD4+ helper T cells. Peptides from viral proteins synthesized in the dendritic cell's OWN cytosol (it is infected) are endogenous → MHC I → presented to CD8+ T cells. One APC can thus launch both arms.

Question 2 — An epithelial cell in the airway is infected but is not an APC. Can it be recognized? Yes. ALL nucleated cells express MHC I, so the epithelial cell displays endogenous viral peptides on MHC I and becomes a target for the CD8+ cytotoxic T cells primed in the node. It cannot present on MHC II — that is reserved for professional APCs.

Question 3 — How do antibodies enter the picture? A B cell whose randomly generated BCR happens to bind a viral surface protein internalizes it and presents fragments on MHC II. A primed CD4+ helper T cell recognizing the same antigen provides contact signals and cytokines (T-dependent activation). The B cell clone expands into plasma cells secreting antibody that neutralizes free virions — note the division of labor: antibody handles EXTRACELLULAR virus, CD8+ cells handle cells already infected.

Question 4 — The student's roommate asks how a receptor for a brand-new virus could already exist. Answer? V(D)J recombination generated an enormous pre-formed repertoire during lymphocyte development; the virus did not instruct receptor design, it merely SELECTED pre-existing clones (clonal selection). The days-long lag of a primary response is the time needed for those rare clones to expand.

T Cells, B Cells & MHC 🎯

Key Takeaways — Part 2

• MHC I: all nucleated cells, ENDOGENOUS peptides, presents to CD8+ cytotoxic T cells; MHC II: professional APCs, EXOGENOUS peptides, presents to CD4+ helper T cells (1 x 8 and 2 x 4)
• Thymic education: positive selection keeps receptors that read self-MHC; negative selection deletes those that bind self too strongly (central tolerance)
• CD4+ helpers conduct via cytokines — Th1 boosts cell-mediated responses, Th2 boosts antibody/humoral responses; CD8+ cells kill via perforin/granzyme and Fas, causing apoptosis
• B cells: T-dependent activation (BCR + MHC II presentation + helper-T contact signals and cytokines) gives class switching and memory; T-independent polysaccharide antigens give mostly IgM, weak memory
• Clonal selection: the receptor repertoire pre-exists antigen thanks to V(D)J somatic recombination and junctional diversity; antigen selects and expands the matching clones

• Low-yield extras: the helper-T contact signal is CD40L binding CD40 on the B cell

Immunology — Deep Dive

Part 3 of 4 — Antibodies, Memory & Vaccination

Antibody Architecture

An antibody (immunoglobulin) is a Y-shaped protein of two identical heavy chains + two identical light chains, held together by disulfide bonds:

• Fab region (the two arms): contains the VARIABLE domains of heavy and light chains; the tips bind the epitope — the specific molecular patch of the antigen. Two arms → two identical binding sites per monomer.
• Fc region (the stem): CONSTANT domains of the heavy chain only. It determines the antibody's class (isotype) and its effector behavior — which cells' Fc receptors it engages, whether it activates complement, whether it crosses the placenta.

Variable region = WHAT is bound; constant region = WHAT HAPPENS next.

The Five Isotypes

What Antibodies Actually Do

Antibodies never kill pathogens directly — they tag and disable:

1. Neutralization: coat toxins or viral attachment proteins so they cannot bind host cells
2. Opsonization: the Fc stem flags the microbe for phagocytes bearing Fc receptors
3. Agglutination: multivalent antibodies (especially pentameric IgM, 10 binding sites) clump pathogens into easily cleared lattices
4. Complement activation: antigen-bound IgM or IgG triggers the classical pathway → opsonization, MAC, inflammation

Improving the Response: Class Switching & Affinity Maturation

• Class switching (isotype switching): a B cell swaps the heavy-chain CONSTANT region (IgM → IgG, IgA, or IgE) under helper-T cytokine direction. The VARIABLE region — and thus antigen specificity — is kept. Same target, new effector toolkit.
• Affinity maturation: in germinal centers, activated B cells undergo somatic hypermutation of their variable-region genes; clones whose mutated receptors bind antigen more tightly outcompete the rest. The average antibody affinity climbs over the course of a response.

Primary vs. Secondary Response

• Primary (first exposure): lag of about 1-2 weeks while rare clones expand; modest peak; IgM first, then some IgG
• Secondary (re-exposure): memory cells respond within days; antibody titer is far higher, predominantly high-affinity IgG, and persists longer

This curve is the entire logic of vaccination: pay the slow primary response against a harmless preparation so the real pathogen meets a secondary response.

Active vs. Passive, Natural vs. Artificial

Passive immunity is immediate but temporary — transferred antibodies degrade over weeks and no memory cells are formed.

Herd immunity: when enough of a population is immune, transmission chains break, indirectly protecting the unvaccinated (infants, the immunocompromised). The required coverage rises with how contagious the pathogen is.

Worked Example — Reading Titer Curves After Vaccination

Passage-style problem. Researchers vaccinate volunteers with a novel protein antigen on day 0 and give a booster on day 60. Serum antibody titers specific to the antigen are measured weekly, distinguishing IgM from IgG. Results:

• Days 0-7: no detectable specific antibody
• Days 10-21: IgM rises first, peaks near day 14, then declines; IgG rises later to a modest peak
• Days 60-67 (after the booster): IgG climbs within ~3-4 days to a level roughly 10-fold higher than the first peak and stays elevated for months; IgM rises only slightly

Question 1 — Why the 10-day silence after the first dose? The volunteers' B-cell repertoires contained only rare clones matching this antigen. Clonal selection, T-dependent activation, and expansion into plasma cells take days — the primary-response lag.

Question 2 — Why is IgM first, then IgG? Naive B cells secrete IgM by default. As helper-T cytokines drive class switching, the SAME variable regions are joined to gamma constant regions, so IgG specific for the antigen appears later. The specificity never changes — only the Fc effector stem.

Question 3 — Explain the booster response's speed, magnitude, and class. Memory B cells generated during the primary response are more numerous than the original naive clones, already class-switched, and carry affinity-matured receptors. Hence the response is faster (days, not weeks), larger (about 10-fold), and predominantly high-affinity IgG — the fingerprint of a secondary response.

Question 4 — A volunteer instead receives pre-formed antibody against the antigen on day 0 and is tested on day 120. Predict the titer. Near zero. Passive antibody transfer provides immediate protection but decays with the IgG half-life (weeks) and generates NO memory cells, because the recipient's own B cells were never activated.

Antibodies & Immunological Memory 🎯

Key Takeaways — Part 3

• Antibody = 2 heavy + 2 light chains joined by disulfide bonds; Fab variable tips bind the epitope, the Fc constant stem sets class and effector function
• Isotypes: IgM first responder (pentamer), IgG serum workhorse (crosses placenta), IgA mucosal dimer, IgE mast cells/allergy/parasites, IgD naive B-cell receptor
• Antibodies tag, never kill: neutralization, opsonization, agglutination, classical complement activation
• Class switching swaps the constant region (keeps specificity); affinity maturation via somatic hypermutation raises binding strength in germinal centers
• Primary response: long lag, IgM-first, modest; secondary: fast, huge, high-affinity IgG — the basis of vaccination
• Active immunity (infection, vaccination) builds memory; passive (maternal IgG/IgA, antivenom) is immediate but temporary with no memory; herd immunity protects the unvaccinated by breaking transmission

Immunology — Deep Dive

Part 4 of 4 — MCAT Integration: Immune Dysfunction & Lab Techniques

Hypersensitivity: Four Ways the System Overreacts

Type I logic: first exposure sensitizes (IgE loads onto mast cells); re-exposure cross-links the IgE → massive histamine release. Type IV is the only antibody-INDEPENDENT type — hence the delay, since T cells must be recruited. Serum sickness's 1-2-week lag is different: it is the time needed to MAKE antibody against a first-time foreign protein.

Autoimmunity: Tolerance Fails

Autoimmune disease = the failure of self-tolerance — self-reactive lymphocytes escape negative selection (or peripheral checkpoints) and attack host tissue. Name-level examples:

• Type 1 diabetes: T-cell destruction of pancreatic beta cells
• Multiple sclerosis: attack on CNS myelin
• Systemic lupus erythematosus: anti-nuclear antibodies; immune complexes (a type III mechanism) damage kidneys, joints, skin

Immunodeficiency: The System Fails

• HIV/AIDS: HIV infects CD4+ helper T cells (using CD4 plus a chemokine co-receptor). Because helpers license BOTH B-cell antibody responses and cytotoxic responses, their loss collapses humoral AND cell-mediated immunity together. Falling CD4 counts track progression; opportunistic infections and rare cancers appear when counts get low.

• The classic AIDS-defining opportunists are Pneumocystis pneumonia and Candida (oral or esophageal thrush).

• SCID (severe combined immunodeficiency): inherited absence of functional B and T cells — "combined" — fatal without intervention (name level).

Blood Typing: Applied Immunology

ABO antigens are carbohydrates on red cells; plasma contains antibodies (mostly IgM) against whichever antigens you LACK:

Transfusion logic: match the DONOR's cell antigens against the RECIPIENT's antibodies. Type O cells carry no ABO antigen to attack → universal donor; type AB plasma attacks nothing → universal recipient.

Rh factor: an Rh- mother carrying an Rh+ fetus can be sensitized at delivery; her anti-Rh IgG (which crosses the placenta, unlike IgM) attacks a SUBSEQUENT Rh+ fetus's red cells — hemolytic disease of the newborn, a type II hypersensitivity. Prevention: anti-Rh antibody (RhoGAM) given to the mother clears fetal cells before she is sensitized.

Lab Techniques as Passage Tools

• ELISA: antibody-based detection in a plate. DIRECT concept: an enzyme-linked antibody binds the target antigen; substrate → color, intensity proportional to amount. INDIRECT concept: the plate presents antigen and the test asks whether the PATIENT'S serum contains antibodies against it (e.g., HIV screening); a labeled anti-human secondary antibody reports the binding.
• Western blot: proteins separated by size (gel electrophoresis), transferred to a membrane, then probed with specific antibody — identity plus approximate size.
• Flow cytometry: cells stream single-file past a laser; fluorescent antibodies against surface markers (e.g., anti-CD4) count cell subsets — this is how clinical CD4 counts are done.

Worked Example — An Rh Pregnancy with ELISA Data

Passage-style problem. A woman with blood type O, Rh-negative has her first child (type A, Rh-positive) with an uneventful delivery. During her second pregnancy (fetus again Rh-positive), an indirect ELISA is run on her serum against Rh(D) antigen coated on the plate, using an enzyme-linked anti-human-IgG secondary antibody. Her absorbance readings are 8-fold above the negative control and rise over the trimester. The second newborn is jaundiced and anemic.

Question 1 — Why was the FIRST Rh+ baby unharmed? Sensitization typically occurs at delivery, when fetal red cells enter maternal circulation. During that first pregnancy the mother had no anti-Rh antibodies yet; her primary response began only after exposure at birth — too late to affect that child.

Question 2 — What does the ELISA result mean, mechanistically? Plate-bound Rh antigen captured maternal anti-Rh antibodies; the anti-IgG secondary bound those and generated signal. So the mother now has class-switched anti-Rh IgG (memory from the first delivery). Rising titers indicate an ongoing secondary response — likely boosted by small fetomaternal bleeds.

Question 3 — Why is the SECOND baby affected, and why does the antibody class matter? Her anti-Rh antibodies are IgG — the only isotype transported across the placenta. They bind fetal Rh+ red cells, marking them for destruction (type II hypersensitivity): hemolysis → anemia; hemoglobin breakdown → bilirubin → jaundice. Had her response remained IgM-only, the pentamer could not cross and the fetus would be spared.

Question 4 — Her anti-A antibodies (she is type O) are mostly IgM. Predict their effect on this type A fetus. Minimal — IgM does not cross the placenta (type O mothers make a little IgG anti-A, so mild ABO disease can occur). This contrast (ABO IgM largely harmless in pregnancy vs. anti-Rh IgG dangerous) is exactly the kind of isotype logic MCAT passages reward.

Question 5 — How does RhoGAM prevent all of this? Anti-Rh antibody given around delivery binds and clears fetal Rh+ cells from maternal blood BEFORE her B cells are activated — passive immunity used to prevent a primary response, so no memory forms.

Immune Dysfunction & Lab Methods 🎯

Key Takeaways — Part 4

• Hypersensitivity: I = IgE/mast cells, immediate (anaphylaxis); II = antibody vs. cell-surface antigen (Rh disease, transfusion reactions); III = immune-complex deposition (lupus nephritis, serum sickness); IV = T-cell mediated and DELAYED (TB test, poison ivy)
• Autoimmunity = failed self-tolerance (type 1 diabetes, MS, lupus); immunodeficiency = failed defense — HIV kills CD4+ helpers and collapses both adaptive arms; SCID = no functional B or T cells
• ABO: your plasma carries IgM against the antigens your cells lack; O = universal RBC donor (no antigens), AB = universal recipient (no antibodies)
• Rh disease: sensitized Rh- mother makes anti-Rh IgG, which crosses the placenta and hemolyzes the next Rh+ fetus's cells (type II); RhoGAM prevents sensitization with passive antibody
• Lab toolkit: ELISA = antibody-based detection (indirect format finds the PATIENT'S antibodies); Western blot = size-separated proteins probed by antibody; flow cytometry = fluorescent-antibody cell counting (clinical CD4 counts)

• Low-yield extras: Pneumocystis pneumonia and Candida thrush are the classic AIDS opportunists